SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-031507
Filing Date
2023-03-13
Accepted
2023-03-13 07:30:35
Documents
12
Period of Report
2023-03-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm232470d2_8k.htm   iXBRL 8-K 26055
  Complete submission text file 0001104659-23-031507.txt   199510

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20230313.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20230313_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20230313_pre.xml EX-101.PRE 22597
6 EXTRACTED XBRL INSTANCE DOCUMENT tm232470d2_8k_htm.xml XML 3606
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 23725705
SIC: 2836 Biological Products, (No Diagnostic Substances)